These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 41655)

  • 1. Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation.
    Bowyer RC; Brockis JG; McCulloch RK
    Clin Chim Acta; 1979 Jul; 95(1):23-28. PubMed ID: 41655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation.
    Ryall RL; Harnett RM; Marshall VR
    J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.
    Fellström B; Lindsjö M; Danielson BG; Karlsson FA; Ljunghall S
    Clin Chim Acta; 1989 Apr; 180(3):213-220. PubMed ID: 2472910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glycosaminoglycans on the crystallisation of calcium oxalate.
    Kohri K; Garside J; Blacklock NJ
    Br J Urol; 1989 Jun; 63(6):584-90. PubMed ID: 2502299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of weddellite formation: chondroitin sulfates and citrate determine weddellite formation in vitro.
    Kim KM
    Scanning Microsc; 1996; 10(2):445-55; discussion 455-7. PubMed ID: 9813623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycans in crystal-surface binding substances and their role in calcium oxalate crystal growth.
    Yoshimura K; Yoshioka T; Miyake O; Honda M; Yamaguchi S; Koide T; Okuyama A
    Br J Urol; 1997 Jul; 80(1):64-8. PubMed ID: 9240182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glycosaminoglycans in tubular epithelial cells: calcium oxalate and oxalate ions effects.
    Borges FT; Michelacci YM; Aguiar JA; Dalboni MA; Garófalo AS; Schor N
    Kidney Int; 2005 Oct; 68(4):1630-42. PubMed ID: 16164640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces.
    Leal JJ; Finlayson B
    Invest Urol; 1977 Jan; 14(4):278-83. PubMed ID: 64463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations upon calcium oxalate crystallization kinetics in simulated urine.
    Miller JD; Randolph AD; Drach GW
    J Urol; 1977 Mar; 117(3):342-5. PubMed ID: 14266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.
    Fellström B; Danielson BG; Ljunghall S; Wikström B
    Clin Chim Acta; 1986 Aug; 158(3):229-35. PubMed ID: 2429785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.